Background: The average cost of insulin has increased greatly recently, partly due to prescription of newer expensive insulins. This has caused insulin underuse among economically vulnerable uninsured patients. Herein, predictors of preference for expensive (higher retail price) insulins among primary care physicians are investigated.
Methods: Internal medicine and family medicine attending physicians and residents at West Suburban Medical Center (Oak Park, Illinois, USA) participated in a web-based survey (Qualtrics Survey Platform) via email between October 20, 2020, and November 10, 2020. Baseline characteristics, prescribing preferences (Insulins Ranks, lower rank indicates higher preference), factors determining insulin choice, pricing knowledge, dosing knowledge, and training were recorded. Insulins were classified as "Inexpensive" (retail price ≤ median insulin price) or "Expensive." The mean rank of expensive and inexpensive insulins prescribed were calculated. Participants were divided into either the "Inexpensive Prescription Preferences" (IPP; mean rank of Inexpensive insulins ≤ mean rank of Expensive insulins) or "Expensive Prescription Preferences" (EPP) groups. Groups were compared. Multivariable logistic regression assessed predictors of IPP.
Results: The response rate was 78% (72/92). Among the 70 participants included, EPP (n = 43) and IPP participants (IPP, n = 27) had similar baseline characteristics (Physician Role, Specialty, and Practice Type), except EPP physicians graduated earlier ( = 0.011). EPP participants reported prescribing insulin glargine more often ( = 0.018) and also ranked it higher ( < 0.001). Logistic regression identified that previous Endocrine rotations ( = 0.031) and senior Physician Role ( = 0.001) predicted EPP.
Conclusion: Previous endocrinology rotations, and senior role predict prescription of insulins with a high retail price. Speculatively, training physicians in cheaper prescription practices may lower costs. Further studies are required to generalize these results.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732847 | PMC |
http://dx.doi.org/10.1210/jendso/bvac170 | DOI Listing |
Health Technol Assess
December 2024
Warwick Evidence, Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK.
Background: Hybrid closed-loop systems are a new class of technology to manage type 1 diabetes mellitus. The system includes a combination of real-time continuous glucose monitoring from a continuous glucose monitoring device and a control algorithm to direct insulin delivery through an insulin pump. Evidence suggests that such technologies have the potential to improve the lives of people with type 1 diabetes mellitus and their families.
View Article and Find Full Text PDFF1000Res
December 2024
Department of Hospital Administration., Datta Meghe Institute of Higher Education and research, Sawangi Meghe, Wardha., Maharashtra, 442001, India.
Introduction: Throughout history and up until the present, there has been a medicine shortage. In the early 1920s, there was a shortage of insulin, which is when drug scarcity first appeared in the records. Drug shortages are now more prevalent globally than they were back then.
View Article and Find Full Text PDFHepatol Commun
December 2024
I. Department of Medicine, University Medical Center of the Johannes Gutenberg, University Mainz, Mainz, Germany.
Background: An increasing number of HCC develops in the context of metabolic dysfunction-associated steatotic liver disease and its inflammatory form, metabolic dysfunction-associated steatohepatitis, even in the absence of cirrhosis. Chronic metabolic inflammation is the driving force of metabolic dysfunction-associated steatotic liver disease progression and a key factor in hepatocarcinogenesis. Given the prominent role of IL-1 signaling in inflammation and metabolic diseases, we investigated the relevance of the hepatocyte-specific IL-1 receptor type 1 knockout in metabolic dysfunction-associated steatohepatitis-related noncirrhotic HCC.
View Article and Find Full Text PDFJ Diabetes Metab Disord
December 2024
Medical Faculty, Ghalib University, Herat, Afghanistan.
Objectives: This study aims to investigate the availability, affordability, and accessibility of antidiabetic medications in Herat, Afghanistan, in 2023.
Methods: Adhering to WHO and HAI guidelines, a systematic survey approach was utilized to collect data on the pricing, availability, and affordability of commonly prescribed antidiabetic medications. Data collection spanned a month and involved four investigators using a standardized template.
PLoS One
November 2024
School of Computer Science, Faculty of Science and Engineering, University of Hull, Hull, United Kingdom.
Type I Diabetes is an endocrine disorder that prevents the pancreas from regulating the blood glucose (BG) levels in a patient's body. The ubiquitous Linear-Quadratic-Integral-Regulator (LQIR) is an optimal glycemic regulation strategy; however, it is not resilient enough to withstand measurement noise and meal disruptions. The Sliding-Mode-Controller (SMC) yields robust BG regulation effort at the expense of a discontinuous insulin infusion rate that perturbs the BG concentrations.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!